Differential effects of androgens and estrogens on bone turnover in normal men

被引:200
作者
Leder, BZ
LeBlanc, KM
Schoenfeld, DA
Eastell, R
Finkelstein, JS
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Biostat, Dept Med, Boston, MA 02114 USA
[3] No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
10.1210/jc.2002-021036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The physiologic role of androgens and estrogens in the maintenance of normal bone turnover in men is a fundamental issue in bone biology. To address this question, we randomized 70 men between the ages of 20 and 44 yr to receive one of three treatment regimens. Group 1 (n = 25) received a GnRH analog (goserelin acetate 3.6 mg by se injection every 4 wk) alone for 12 wk to suppress endogenous gonadal steroids to prepubertal levels. Group 2 (n = 22) received goserelin plus transdermal testosterone (Androderm 5 mg topically daily) to normalize circulating testosterone and estradiol levels. Group 3 (n = 23) received goserelin plus testosterone plus an aromatase inhibitor (anastrozole 1 mg orally daily) to induce selective estrogen deficiency. The selective effects of androgens and estrogens on skeletal homeostasis were then assessed by measuring changes in biochemical markers of bone turnover and analyzing the between-group differences. Bone resorption markers increased in both the hypogonadal group (group 1) and in the group with selective estrogen deficiency (group 3). Urinary deoxypyridinoline excretion increased more in group 1 than in group 3 (P = 0.023), suggesting a significant effect of androgens on bone resorption, whereas serum N-telopeptide levels increased more in group 3 than in group 2 (P = 0.037), suggesting a significant effect of estrogen on bone resorption. Bone formation markers initially declined in all groups and then increased in groups 1 and 3. The between-group comparisons were consistent for all formation markers. Bone formation markers increased more in group 1 than in group 2 (P = 0.001, 0.037, 0.005 for osteocalcin, carboxyterminal propeptide of type I procollagen, and amino-terminal propeptide of type I procollagen, respectively). Bone formation markers also increased more in group I than in group 3 but these differences were not statistically significant (P = 0.065 0.073, 0.099 for osteocalcin, carboxy-terminal propeptide of type I procollagen, and amino-terminal propeptide of type I procollagen, respectively). Taken together, these data suggest that both androgens and estrogens play independent and fundamental roles in regulating bone resorption in men. These data also suggest that androgens may play an important role in the regulation of bone formation in men.
引用
收藏
页码:204 / 210
页数:7
相关论文
共 41 条
[1]  
ALBRIGHT FULLER, 1940, TRANS ASSOC AMER PHYSICIANS, V55, P298
[2]   Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the framingham study [J].
Amin, S ;
Zhang, YQ ;
Sawin, DT ;
Evans, SR ;
Hannan, MT ;
Kiel, DP ;
Wilson, PWF ;
Felson, DT .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) :951-963
[3]   Low levels of estradiol are associated with vertebral fractures in older men, but not women:: The Rancho Bernardo study [J].
Barrett-Connor, E ;
Mueller, JE ;
Von Mühlen, DG ;
Laughlin, GA ;
Schneider, DL ;
Sartoris, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :219-223
[4]   REGULATION OF INTERLEUKIN-6, OSTEOCLASTOGENESIS, AND BONE MASS BY ANDROGENS THE ROLE OF THE ANDROGEN RECEPTOR [J].
BELLIDO, T ;
JILKA, RL ;
BOYCE, BF ;
GIRASOLE, G ;
BROXMEYER, H ;
DALRYMPLE, SA ;
MURRAY, R ;
MANOLAGAS, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2886-2895
[5]   Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency [J].
Bilezikian, JP ;
Morishima, A ;
Bell, J ;
Grumbach, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :599-603
[6]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95
[7]   Hormonal and biochemical parameters in the determination of osteoporosis in elderly men [J].
Center, JR ;
Nguyen, TV ;
Sambrook, PN ;
Eisman, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3626-3635
[8]   Clinical pharmacokinetics of goserelin [J].
Cockshott, ID .
CLINICAL PHARMACOKINETICS, 2000, 39 (01) :27-48
[9]   IDENTIFICATION OF ANDROGEN RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
COLVARD, DS ;
ERIKSEN, EF ;
KEETING, PE ;
WILSON, EM ;
LUBAHN, DB ;
FRENCH, FS ;
RIGGS, BL ;
SPELSBERG, TC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :854-857
[10]   EVIDENCE OF ESTROGEN-RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
ERIKSEN, EF ;
COLVARD, DS ;
BERG, NJ ;
GRAHAM, ML ;
MANN, KG ;
SPELSBERG, TC ;
RIGGS, BL .
SCIENCE, 1988, 241 (4861) :84-86